发明名称 CB1 RECEPTOR MODULATORS
摘要 Compounds of formula (I) suppress the normal signalling activity of cannabinoid receptor CB1 and are therefore useful inter alia in the treatment of conditions directly or indirectly associated with obesity and overweight, Wherein A1 is -COOH or tetrazolyl; R2, R3, R'2 and R'3 are independently selected from -R9, - CN, -F1 -Cl, -Br, -OR9, or -SR9; R9 is hydrogen, C1-C3 alkyl, cycloalkyl, or fully or partially fluorinated C1-C3 alkyl; R1 is (i) a bond, or (H) -C(R10)(R11)-*. -C(R10)(R11)-O-*. -C(R10)(R11)CH2*, or -CH2C(R10)(R11)-*, wherein the bond indicated by an asterisk is attached to Ring A ring; R10 is hydrogen and R11 is hydrogen, (C1-C3)alkyl or -OH; or R10 and R11 are both (C1-C3)alkyl; or R10 and R11 taken together with the carbon atom to which they are attached form a (C3-C5)cycloalkyl ring; Ring A is an aromatic ring as specified in the claims; Z1 is a moncyclic group as specified in the claims.
申请公布号 WO2009153569(A3) 申请公布日期 2010.02.04
申请号 WO2009GB01539 申请日期 2009.06.18
申请人 7TM PHARMA A/S;MURRAY, ANTHONY;HOEGBERG, THOMAS;COOPER, MARTIN;BJURLING, EMELIE;RECEVEUR, JEAN-MARIE;NOERREGAARD, PIA, KARINA 发明人 MURRAY, ANTHONY;HOEGBERG, THOMAS;COOPER, MARTIN;BJURLING, EMELIE;RECEVEUR, JEAN-MARIE;NOERREGAARD, PIA, KARINA
分类号 C07D401/06;A61K31/4178;A61P3/04;C07D403/06 主分类号 C07D401/06
代理机构 代理人
主权项
地址